-
Association of healthy sleep pattern with lower risk of acute myocardial infarction mortality among people with diabetes: A prospective cohort study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Min Du, Min Liu, Jue Liu
-
Microbial and metabolomic profiles of type 1 diabetes with depression: A case–control study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Ziyu Liu, Tong Yue, Xueying Zheng, Sihui Luo, Wen Xu, Jinhua Yan, Jianping Weng, Daizhi Yang, Chaofan Wang
-
Increased risk of cardiovascular and renal disease, and diabetes for all women diagnosed with gestational diabetes mellitus in New Zealand—A national retrospective cohort study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Barbara M. Daly, Zhenqiang Wu, Krishnarajah Nirantharakumar, Lynne Chepulis, Janet A. Rowan, Robert K. R. Scragg
-
Mitochondria‐associated membranes contribution to exercise‐mediated alleviation of hepatic insulin resistance: Contrasting high‐intensity interval training with moderate‐intensity continuous training in a high‐fat diet mouse model J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Xi Li, Jun Yang Yang, Wen Zhi Hu, YuXin Ruan, Hong Ying Chen, Qiang Zhang, Zhe Zhang, Zhe Shu Ding
-
Traditional and emerging strategies using hepatocytes for pancreatic regenerative medicine J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Shuang Liu, YuYing Zhang, YunFei Luo, JianPing Liu
-
Advanced multifunctional hydrogels for diabetic foot ulcer healing: Active substances and biological functions J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Yuetong Li, Yuxin Leng, Yang Liu, Jianhua Zhong, Jiaxin Li, Shitong Zhang, Zhenlin Li, Kaming Yang, Xinyi Kong, Wanwen Lao, Changlong Bi, Aixia Zhai
-
Financial conflicts of interest among authors of clinical practice guidelines for diabetes mellitus in Japan J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Anju Murayama
Clinical practice guidelines (CPGs) serve as pivotal frameworks for standardizing evidence-based diagnostic and therapeutic approaches, particularly in the management of diabetes and beyond.1, 2 However, the integrity of these guidelines can be compromised by conflicts of interest (COIs).3-5 Given that current increasing attention from pharmaceutical companies to diabetologists6, 7 and large prevalence
-
Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Yu‐Jiao Li, Zi‐Yue Shao, Yun‐Qing Zhu, Da‐Shuang Chen, Jian Zhu
-
Association of advanced glycation end products with ear lobe crease: A cross‐sectional study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Yuepeng Wang, Yu Xin, Binqi Li, Qingzheng Wu, Ping An, Bing Li, Yijun Li, Li Zang, Weijun Gu, Yiming Mu
-
Independent and interactive associations of heart rate and obesity with type 2 diabetes mellites: A population‐based study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Tianxin Zhu, Qingyu Chen, Hongxing Chen, Lili You, Dan Liu, Xiaoyun Zhang, Feng Li, Hongshi Wu, Juying Tang, Diaozhu Lin, Kan Sun, Li Yan, Meng Ren
-
Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Joanna Helena Sliwowska, Nicola Elizabeth Woods, Abdullah Rzgallah Alzahrani, Elpiniki Paspali, Rothwelle Joseph Tate, Valerie Anne Ferro
-
Association of obstructive sleep apnea symptoms with all‐cause mortality and cause‐specific mortality in adults with or without diabetes: A cohort study based on the NHANES J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Qian Zhang, Qi Zhang, Xiaomin Li, Gang Du, Xiaojin Feng, Runtao Ding, Yuhua Chi, Yongping Liu
-
FSH regulates glucose‐stimulated insulin secretion: A bell‐shaped curve effect J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Hong Zhu, Guolian Ding, Hefeng Huang
Follicle-stimulating hormone (FSH), a classical hormone derived from the pituitary, primarily affects the gonads and regulates the reproductive process.1 FSH consists of an α and a β subunit, with the β subunit specifically binding to its G protein-coupled receptor (GPCR), FSHR.2 The FSHR mediates the transduction of the FSH-induced signal. According to the recent work published in Nature Communications
-
The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study J. Diabetes (IF 4.5) Pub Date : 2024-04-11 Kate E. D. Ziser, Stephen Wood, George S. Q. Tan, Jedidiah I. Morton, Jonathan E. Shaw, J. Simon Bell, Jenni Ilomaki
-
Association of cardiovascular disease prevalence with BMD and fracture in men with T2DM J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Xiao‐ke Kong, Rui Xie, Deng Zhang, Xiao‐jing Chen, Xiao‐feng Wang, Jie‐li Lu, Hong‐yan Zhao, Jian‐min Liu, Li‐hao Sun, Bei Tao
-
-
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Lingding Xie, Jie Han, Zhifeng Cheng, Dexue Liu, Jie Liu, Chunrong Xu, Wenli Sun, Qingju Li, Fang Bian, Wei Zhang, Jinyu Chen, Qian Zhu, Tara K. Thurber, J. Paul Lock, Bo Zhang
-
Traditional Chinese medicine could play an important role in diabetes management: Commentary on “National Chinese medicine guideline for the prevention and treatment of diabetes in primary care (2022)” J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Liyan Jia, Chen Shen, Baoyong Lai, Caoxin Huang, Nengjiang Zhao, Bo Li, Zhihai Zhang, Miaona Cai, Bing Yan, Jianping Liu, Shuyu Yang
According to the latest data from International Diabetes Federation, China has the largest number of adults with diabetes, with ~140.9 million people having the disease.1 Traditional Chinese medicine (TCM) is one of the earliest complementary and alternative medicines worldwide to explore the prevention and treatment of diabetes.2 Nowadays, TCM is being increasingly utilized as adjuvant therapy for
-
Further learning of clinical characteristics and imaging manifestations of nonketotic hyperglycemic hemichorea J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Xiaoyu Wang, Yuting Zhang, Fan Yang, Suqing Bao, Lijun Duan, Xia Jiang
-
Exercise‐induced improvement of glycemic fluctuation and its relationship with fat and muscle distribution in type 2 diabetes J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Dan Liu, Ying Zhang, Qian Wu, Rui Han, Di Cheng, Liang Wu, Jingyi Guo, Xiangtian Yu, Wenli Ge, Jiacheng Ni, Yaohui Li, Tianshu Ma, Qichen Fang, Yufei Wang, Yan Zhao, Yanan Zhao, Biao Sun, Huating Li, Weiping Jia
-
Pedal medial arterial calcification in diabetic foot ulcers: A significant risk factor of amputation and mortality J. Diabetes (IF 4.5) Pub Date : 2024-04-08 Lihong Chen, Dawei Chen, Hongping Gong, Chun Wang, Yun Gao, Yan Li, Weiwei Tang, Panpan Zha, Xingwu Ran
-
The WCIRDC 2023: Concepts of insulin resistance J. Diabetes (IF 4.5) Pub Date : 2024-03-22 Zachary Bloomgarden
The 21st annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, held in Los Angeles, California on December 7–9, 2023, included 69 presentations spanning a myriad of aspects of diabetes and its complications, of atherosclerosis, of renal disease, of liver disease, and of novel therapeutic approaches. For this summary, we will focus on presentations illustrating the current
-
Impact of treatment with GLP‐1RAs on suicide attempts in adults persons with type 2 diabetes: A retrospective comparative effectiveness study based on a global TriNetX health research database J. Diabetes (IF 4.5) Pub Date : 2024-03-19 Mahmoud Nassar, Anoop Misra, Zachary Bloomgarden
-
-
Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real-world data from the German/Austrian DPV registry J. Diabetes (IF 4.5) Pub Date : 2024-02-25 Alexander J. Eckert, Stefan Zimny, Marcus Altmeier, Ana Dugic, Anton Gillessen, Latife Bozkurt, Gabriele Götz, Wolfram Karges, Frank J. Wosch, Stephan Kress, Reinhard W. Holl
-
Deciphering the connection: Diabetes, pericyte dysfunction, and their impact on cardiovascular health J. Diabetes (IF 4.5) Pub Date : 2024-02-26 Robert Chilton, Elham I. Iranpour, Zachary Bloomgarden
In the intricate tapestry of human biology, diabetes mellitus silently threads its way, casting unseen webs across the expanse of global health.1 This enduring metabolic disorder, characterized by elevated blood glucose levels, poses a challenge that extends beyond its well-documented impact on blood vessels. Unbeknownst to many, diabetes conducts a symphony of disruption, particularly affecting the
-
Measurement of renal function: Should cystatin C be more widely used for people with diabetes? J. Diabetes (IF 4.5) Pub Date : 2024-01-28 Christian W. Mende, Zachary Bloomgarden
Chronic kidney disease (CKD) affects about 10% of the adult population worldwide1 and 14% of the adult population of the United States.2 CKD is diagnosed by either of two criteria being present for 3 months or longer: measured renal function using the recently updated race free Chronic Kidney Disease Epidemiology (CKD-EPI) 2021 formula with an estimated glomerular filtration rate (eGFR) <60 mL/min/1
-
Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1 and type 2 diabetes in Finland in 2012–2019: Nationwide real-world evidence study J. Diabetes (IF 4.5) Pub Date : 2024-01-25 Leo Niskanen, Minna Hannula, Kai Kysenius, Saara Kaijala, Mariann I. Lassenius, Timo T. Valle
-
Commentary on the T1D exchange quality improvement collaborative learning session November 2023 abstracts J. Diabetes (IF 4.5) Pub Date : 2024-01-17 Shideh Majidi, Shivani Agarwal, Nicole Rioles, Robert Rapaport, Osagie Ebekozien
1 INTRODUCTION The T1D Exchange Quality Improvement Collaborative (T1DX-QI), established in 2016, aims to refine best practices, emphasize quality of care, and improve diabetes outcomes across the country in those with type 1 diabetes (T1D).1 T1DX-QI includes over 55 diabetes centers, including both adult and pediatric diabetes centers, allowing it to investigate and improve diabetes care for over
-
Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: A 5-year follow-up study J. Diabetes (IF 4.5) Pub Date : 2024-01-15 Yuanpin Zhang, Wanwan Sun, Qi Zhang, Yuetian Bai, Lijin Ji, Hangping Zheng, Xiaoming Zhu, Xiaoxia Liu, Shuo Zhang, Qian Xiong, Yiming Li, Lili Chen, Bin Lu
-
Liraglutide does not increase heart rate of diabetic patients during acute myocardial infarction J. Diabetes (IF 4.5) Pub Date : 2024-01-03 Qianyi Li, Chunxuan Wu, Shiqun Sun, Lingchao Yang, Yanyan Li, Yixin Niu, Li Zhang, Wei Li, Ying Yu
-
A novel simple disposition index (SPINA-DI) from fasting insulin and glucose concentration as a robust measure of carbohydrate homeostasis J. Diabetes (IF 4.5) Pub Date : 2024-01-02 Johannes W. Dietrich, Assjana Abood, Riddhi Dasgupta, Shajith Anoop, Felix K. Jebasingh, R. Spurgeon, Nihal Thomas, Bernhard O. Boehm
-
Exploring factors associated with self-rated health in individuals with diabetes and its impact on quality of life: Evidence from the Survey of Health, Ageing, and Retirement in Europe J. Diabetes (IF 4.5) Pub Date : 2024-01-02 Rosa Marie Brückner, Aline Schönenberg, Rebecca Wientzek, Mandy Schreiber, Tino Prell
-
Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes J. Diabetes (IF 4.5) Pub Date : 2024-01-02 Liang Feng, Yong Mong Bee, Xiuju Fu, Jia Liang Kwek, Choong Meng Chan, Tazeen H. Jafar
-
Diabetic neuropathy: A NRF2 disease? J. Diabetes (IF 4.5) Pub Date : 2023-12-29 Monica Neagu, Carolina Constantin, Mihaela Surcel, Adriana Munteanu, Cristian Scheau, Ilinca Savulescu-Fiedler, Constantin Caruntu
-
Bariatric surgery induces pancreatic cell transdifferentiation as indicated by single-cell transcriptomics in Zucker diabetic rats J. Diabetes (IF 4.5) Pub Date : 2023-12-27 Yongjun Liang, Jason Widjaja, Jiawei Sun, Mengyi Li, Zhengdong Qiao, Ting Cao, Yueqian Wang, Xiong Zhang, Zhongtao Zhang, Yan Gu, Peng Zhang, Jianjun Yang
-
Pulmonary disease in diabetes J. Diabetes (IF 4.5) Pub Date : 2023-12-29 Zachary Bloomgarden
Diabetes is associated with a variety of pulmonary disorders beyond its associations with sleep apnea discussed in the previous commentary. The Fremantle Diabetes Study in Western Australia showed that persons with type 2 diabetes (T2D) had 5%–12% reduction in vital capacity and expiratory flow rates with evidence of worsening over a 7-year period of observation; in follow-up, each 10% reduction in
-
Closed-loop systems in Type 1 diabetes and antitumor necrosis factor alpha therapy: Are currently available algorithms prepared for sudden changes in insulin sensitivity? J. Diabetes (IF 4.5) Pub Date : 2023-12-19 Lía Nattero-Chávez, Jorge Bondía, Héctor F. Escobar-Morreale, Manuel Luque-Ramírez
Automated insulin delivery by closed-loop systems (CLS) improves metabolic control in Type 1 diabetes (T1D), providing a flexible platform capable of matching their changing insulin requirements.1 We hereby report the case of a 24-year-old woman being adequately controlled by a CLS, whose T1D became unstable following a tumor necrosis factor alpha inhibitor (iTNF-α). After onset of diabetes at the
-
Long noncoding RNAs as potential diagnostic biomarkers for diabetes mellitus and complications: A systematic review and meta-analysis J. Diabetes (IF 4.5) Pub Date : 2023-12-23 Xuee Su, Huibin Huang, Jinqing Lai, Shu Lin, Yinqiong Huang
-
Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes J. Diabetes (IF 4.5) Pub Date : 2023-12-20 Stephanie Vermeulen, Mirjam E. A. Scheffer-Rath, Martine T. P. Besouw, Amarens van der Vaart, Martin H. de Borst, Annemieke M. Boot
-
Pravastatin promotes type 2 diabetes vascular calcification through activating intestinal Bacteroides fragilis to induce macrophage M1 polarization J. Diabetes (IF 4.5) Pub Date : 2023-12-19 Cong Chen, Zheng-Feng Liang, Yu-Qi He, An-Qi Li, Yan Gao, Qun-Wen Pan, Jing-Song Cao
-
The impact of a diabetes diagnosis on health and well-being: Findings from the English Longitudinal Study of Ageing J. Diabetes (IF 4.5) Pub Date : 2023-12-19 Camilla Böhme Kristensen, Joseph Chilcot, Sarah E. Jackson, Andrew Steptoe, Ruth A. Hackett
-
Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL-AF registry J. Diabetes (IF 4.5) Pub Date : 2023-12-14 Rungroj Krittayaphong, Thanita Boonyapiphat, Arjbordin Winijkul, Gregory Y. H. Lip
-
Duodenal-jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats J. Diabetes (IF 4.5) Pub Date : 2023-12-12 Guangwei Yang, Zitian Liu, Shuohui Dong, Xiang Zhao, Zheng Ge, Zhiqiang Cheng, Xiang Zhang, Kexin Wang
-
Clinical and genetic characteristics of maturity-onset diabetes of the young type 13: A systematic review of the literature J. Diabetes (IF 4.5) Pub Date : 2023-12-14 Yaning Chen, Xiaodong Hu, Mingwei Zhao
-
Association of methylation risk score with incident type 2 diabetes mellitus: A nested case–control study J. Diabetes (IF 4.5) Pub Date : 2023-12-07 Weifeng Huo, Huifang Hu, Tianze Li, Lijun Yuan, Jinli Zhang, Yifei Feng, Yuying Wu, Xueru Fu, Yamin Ke, Mengmeng Wang, Wenkai Zhang, Longkang Wang, Yaobing Chen, Yajuan Gao, Xi Li, Jiong Liu, Zelin Huang, Fulan Hu, Ming Zhang, Liang Sun, Dongsheng Hu, Yang Zhao
-
Estimated glomerular filtration rate and risk of all-cause mortality J. Diabetes (IF 4.5) Pub Date : 2023-12-04 Tomoyuki Kawada
Liu et al.1 conducted a prospective study to examine the associations between several estimated glomerular filtration rates (eGFRs) and all-cause mortality with special reference to diabetes status. The mean age of the subjects was about 60 years, and eGFR measure was classified into three groups: normal, modestly declined, and chronic kidney disease (CKD). The adjusted hazard ratio (HR) of CKD defined
-
Ubiquitin-conjugating enzyme E2 for regulating autophagy in diabetic cardiomyopathy: A mini-review J. Diabetes (IF 4.5) Pub Date : 2023-12-05 Yueran Zhou, Zequn Zheng, Shenglin Wu, Jinxiu Zhu
-
Lipocalin 2—A bone-derived anorexigenic and β-cell promoting signal: From mice to humans J. Diabetes (IF 4.5) Pub Date : 2023-11-30 Yuying Yang, Jianmin Liu, Stavroula Kousteni
-
Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease J. Diabetes (IF 4.5) Pub Date : 2023-11-30 Lin Yang, Yan Shen, Wenxiao Li, Bingbing Zha, Wenjun Xu, Heyuan Ding
-
Diagnostic biomarker for type 2 diabetic peripheral neuropathy via comprehensive bioinformatics analysis J. Diabetes (IF 4.5) Pub Date : 2023-11-29 Xiaoyu Chen, Qingquan Liu, Niyao Chen, Jiangxin Ma, Xiaohong Wu, Haibin Zhang, Liying Yu, Huibin Huang
-
Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 J. Diabetes (IF 4.5) Pub Date : 2023-11-27 Minmin Wang, Jingyi Liu, Jia Wang, Yinzi Jin, Zhi-Jie Zheng
-
Temporal associations of diabetes-related complications with health-related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults—Joint Asia Diabetes Evaluation (JADE) register (2007–2018) J. Diabetes (IF 4.5) Pub Date : 2023-11-20 Juliana N. M. Lui, Eric S. H. Lau, Aimin Yang, Hongjiang Wu, Amy Fu, Vanessa Lau, Kitman Loo, Theresa Yeung, Rebecca Yue, Ronald C. W. Ma, Alice P. S. Kong, Risa Ozaki, Andrea O. Y. Luk, Elaine Y. K. Chow, Juliana C. N. Chan
-
Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) ± glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetes J. Diabetes (IF 4.5) Pub Date : 2023-11-20 Leigh Perreault, Bryan C. Bergman
Highlights
-
Lower urinary albumin-to-creatinine ratio predicted all-cause and cardiovascular mortality in Chinese population with diabetes and prediabetes—The Shanghai Changfeng cohort study J. Diabetes (IF 4.5) Pub Date : 2023-11-20 Lingyan Chen, Li Wu, Qian Li, Hui Ma, Ting Liu, Jing Li, Baisheng Pan, Yu Hu, Huandong Lin, Xin Gao
-
Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria J. Diabetes (IF 4.5) Pub Date : 2023-11-16 Yufang Liu, Sanbao Chai, Xiaomei Zhang
-
The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes J. Diabetes (IF 4.5) Pub Date : 2023-11-14 Joseph Henson, Melanie J. Davies, Emer M. Brady, Charlotte L. Edwardson, Andrew P. Hall, Kamlesh Khunti, Emma Redman, Alex V. Rowlands, Jack Sargeant, Thomas Yates
-
Association of remnant cholesterol and newly diagnosed early-onset type 2 diabetes mellitus in Chinese population: A retrospective cross-sectional study J. Diabetes (IF 4.5) Pub Date : 2023-11-14 Wenjing Dong, Shiju Yan, Han Chen, Jian Zhao, Zengqiang Zhang, Weijun Gu
-
Type 1 diabetes prevention and treatment: Time to think outside the box J. Diabetes (IF 4.5) Pub Date : 2023-11-13 Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro
Atkinson and Mirmira1 point out that the actual abnormalities in type 1 diabetes (T1D) lie beyond the three classic seminal observations of inflammatory infiltrate of islets, genetic susceptibility associated with the major histocompatibility complex, and autoantibodies against β-cell antigens. Indeed, many other abnormalities are present in T1D, including dysfunction of α cells, abnormalities of the
-
November 14–15, 2023, T1DX-QI Learning Session, Journal of Diabetes Abstracts J. Diabetes (IF 4.5) Pub Date : 2023-11-05